Our sector team has helped industry organizations address strategic and transformation opportunities for over 25 years. We work with leading pharmaceutical, biotech, medical device and diagnostic companies. The sector team also covers animal health, agri-chemical and specialized distribution.
In 2011, we established a dedicated oncology unit in partnership with Novo Oncology Associates. The unit combines scientific expertise, strategic consulting skills and a network of key opinion leaders to meet clients’ needs in this highly-specialized area. Our oncology services include portfolio strategy, commercialization and lifecycle management.
Track record and value delivery
Leveraging the breadth of Capgemini Consulting, our teams bring leading practices from other industries that can help accelerate our clients’ transformation (e.g. customer analytics from financial services, digital strategy from telecoms, supply chain excellence from process manufacturing).
The life sciences team often leverages Capgemini’s Accelerated Solutions Environment (ASE) to develop creativity and innovation across organizations and to bring added value in solving complex business issues.
What we offer
- Strategy and Digital Innovation
Define and execute corporate, franchise and functionnal strategies to enable a path to growth and profitability and innovate through digital strategies.
- Commercial Transformation
Design and implement an innovative and cost effective comm commercial model.Product Launch
Prepare and execute quality launches with cross-functional participation and clear accountability.
- Oncology Strategy and Commercialization
Develop and sustain a successful oncology franchise through effective portfolio and commercializationstrategies.
- Healthcare Reform
Understand and respond to the changes in healthcare policy around the globe.
- Organizational Effectiveness
Improve organizational effectiveness to meet today’s innovation and bottom line challenges.
- Research and Development Effectiveness
Reshape innovation management by redesigning R&D strategies and operating models.
- Operations Optimization
The convergence of patient, payer, and industry issues is threatening long-established business models and driving life sciences companies to optimize their supply networks.